Author Search Results :: UTM Library Massive Scholar Tracking

1

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection by Elisa Roldan, Miguel Angel Perales, Pere Barba

Published 2019-09-01

Get full text

Article

2

P406: INCIDENCE OF COMPLICATIONS OF HIGH-DOSE METHOTREXATE ADMINISTRATION IN ADULTS AND CHILDREN WITH HEMATOLOGIC CANCERS: PRELIMINARY RESULTS FROM A EUROPEAN REGISTRY by Scott Howard, Ryan Combs, Jennifer Lowe, Carmelo Rizzari, María Dolores Aumente, Pere Barba Suñol, Thais Murciano, Margarita Satostegui, Claudia Sampor, Nicolás Tentoni

Published 2023-08-01

Get full text

Article

3

Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study by Antonio Pérez-Martínez, Carlos Solano, Mi Kwon, Joaquín Martinez, Anna Sureda, Pedro Castro-Rebollo, Lucia López-Corral, Pere Barba-Suñol, Valentín Ortiz, Jaime Sanz-Caballer, Ana Carolina Caballero, Ángel Cedillo

Published 2023-07-01

Get full text

Article

4

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy by Marta Grau-Vorster, Marta Grau-Vorster, María López-Montañés, María López-Montañés, Ester Cantó, Ester Cantó, Joaquim Vives, Joaquim Vives, Joaquim Vives, Irene Oliver-Vila, Pere Barba, Sergi Querol, Francesc Rudilla, Francesc Rudilla

Published 2020-02-01

Get full text

Article

5

PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma by Marta Ligero, Marc Simó, Cecilia Carpio, Gloria Iacoboni, Maria Balaguer‐Montero, Victor Navarro, Mario Andres Sánchez‐Salinas, Sabela Bobillo, Ana Marín‐Niebla, Josu Iraola‐Truchuelo, Pau Abrisqueta, Roser Sala‐Llonch, Francesc Bosch, Raquel Perez‐Lopez, Pere Barba

Published 2023-11-01

Get full text

Article

6

$LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus$

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythemat... by Giulio Cavalli, Julia Weinmann-Menke, Clive Drakeford, Mi Kwon, Peter Gergely, Tamas Shisha, Pere Barba, Eva Wagner-Drouet, Josefina Cortés Hernández, José María Álvaro-Gracia Álvaro, Ozana Fischer, Beata Kovacs, Frédérique Chaperon, David Pearson, Tiina Kirsilä, Chih-Yung Sean Lee

Published 2024-03-01

Article

7

Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle by Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet Markman, Magdalena Nauerth, Helene Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger

Published 2023-12-01

Get full text

Article

8

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL by Marion Subklewe, Veit Bücklein, Cecilia Carpio, Frederick L Locke, Andreas Mackensen, Dimitrios Mougiakakos, Michael von Bergwelt-Baildon, Pere Barba, Wolfgang Bethge, Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Liv Jentzsch, Grace Johnson, Brian Arciola, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Michael D Jain

Published 2022-05-01

Get full text

Article

9

$Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma$

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma by Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez‐Cibrian, Rebeca Bailén, Lucia Lopez Corral, Jose M. Sanchez, Manuel Guerreiro, Ana Carolina Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martin Garcia‐Sancho, Mi Kwon, Juan Luis Reguera‐Ortega, Pere Barba, GETH, GELTAMO Spanish Groups

Published 2021-05-01

Get full text

Article

10

$Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL$

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL by Kai Rejeski, Viktoria Blumenberg, Gloria Iacoboni, Lucia Lopez-Corral, Soraya Kharboutli, Rafael Hernani, Agnese Petrera, Niklas Müller, Friederike Hildebrand, Lisa Frölich, Philipp Karschnia, Christian Schmidt, David M. Cordas dos Santos, José Luis Piñana, Fabian Müller, Ana Africa Martin, Martin Dreyling, Michael von Bergwelt-Baildon, Pere Barba, Marion Subklewe, Veit L. Bücklein

Published 2023-04-01

Get full text

Article

11

$Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use$

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammatio... by Veit Bücklein, Ariel Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic, Udo Holtick, Olaf Penack, Soraya Kharboutli, Viktoria Blumenberg, Josephine Ackermann, Lisa Frölich, Grace Johnson, Kedar Patel, Brian Arciola, Rahul Mhaskar, Anthony Wood, Christian Schmidt, Omar Albanyan, Philipp Gödel, Eva Hoster, Lars Bullinger, Andreas Mackensen, Frederick Locke, Michael von Bergwelt, Pere Barba, Marion Subklewe, Michael D. Jain

Published 2023-08-01

Get full text

Article

12

P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY by Gloria Ines Iacoboni Garcia-Calvo, Victor Navarro, Ana Africa Martin Lopez, Mariana Bastos Oreiro, Kai Rejeski, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera Ortega, Viktoria Blumenberg, Laura Gallur, María Herrero-García, Claire Roddie, Rebeca Bailen, Ana Benzaquen, Cecilia Carmen Carpio Segura, Lucía López Corral, Rafael Hernani, MI Kwon, Lourdes Martín-Martín, Marion Subklewe, Maeve O’reilly6, Pere Barba Suñol

Published 2023-08-01

Get full text

Article

13

$Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups$